NOTOX

NOTOX COLLABORATION WITH SEMLER RESEARCH CENTER IN INDIA
20 October 2009

‘S-Hertogenbosch, Netherlands, October 2009 – NOTOX B.V. is pleased to announce collaboration with Semler Research Center (SRC) in India.

Together, SRC and NOTOX shall integrate their service offerings through scientific collaboration, sharing of best practices and marketing to provide a seamless bridge between these two highly regarded scientific organizations. SRC has significant expertise in a diverse range of techniques and assays supporting clinical toxicological, pharmacological, and pharmacokinetic and bioequivalence studies (phase I unit). SRC complements NOTOX’s contract research service offerings that include expertise in preclinical contract research and expert consultancy for the development of pharmaceutical products worldwide.

“This collaboration will effectively and successfully offer full fledged preclinical services to the Indian Pharma Industry and further strengthens the service portfolio of SRC” says Ravi Achar, CFO and Managing Director Semler Research Center.

“Having on the ground representation will enhance our existing relationship with our Indian clients and open the door to building more” says Wilbert Frieling, Managing Director NOTOX BV.

Offering this wide range of services helps our global pharmaceutical and biotech clients significantly enhance their product development success from both a cost and turnaround standpoint while maintaining the highest levels of quality.

Contact Europe:                                                      Contact India:
Drs. Marcel Hermanussen                                  R.L.K. Agnihotri
Head of Sales & Marketing                                   Vice President Business Development &
                                                                                        Corporate Development
NOTOX B.V.                                                                Semler Research Center
marcel.hermanussen@notox.nl                       agnihotri@semlerresearch.com
+31 73 640 6716                                                    +91 2664 0681/82 ext 213

Note for the editor:
Semler Research Center was founded late 2005 by Ronald Semler (Chairman), Ravi Achar (CFO and Managing Director) and Dr. Guru Betageri (Director). Gurudatta GG is the Chief Operating Officer. SRC has its R & D Centre in a 15,000 sqft state-of-the-art facility housing Formulation Development and Bioanalytical Research labs, located in Bangalore, India and a Clinical Center, located in Salem, India on a 11,000 sqft 48 bed facility with all necessary clinical capabilities. SRC has highly competent scientific operations team and has an established track record with pharma clients all over the world. SRC has its corporate headquarters in Los Angeles, USA, and is part of the Semler group of companies that have been in business in other industries since 1946.
For more information please visit: www.semlerresearch.com

NOTOX B.V. was founded in 1983 and evolved as a privately held company until 2005. In this year NOTOX become part of the worldwide group of autonomous companies WIL Research Company Inc., providing toxicology and formulation research services. This Trans-Atlantic presence was built with a vision to seamlessly address the service needs of international industry partners and ranks in the top 7 CRO’s worldwide.

NOTOX specializes in personalized contract research and expert consultancy for the registration of pharmaceutical products and (agro)chemicals worldwide. 300 well-trained and dedicated specialists and 12,300 m2 of modern purpose built laboratories and offices are available to perform your regulatory toxicology studies. Our operations have been endorsed by the GLP Monitoring authorities (OECD/EPA/FDA/JMAFF certification). In addition to the headquarters in 's-Hertogenbosch, the Netherlands, NOTOX has support offices in Japan, Switzerland, USA and new representation in India.
Services provided by NOTOX B.V.: dedicated and crystal clear.
For more information please visit: www.notox.nl